AbbVie Inc. is challenging the Trump administration’s decision to select its Botox drug for a government program that slashes ...
In response to last month’s list of the 15 drugs chosen by the Centers for Medicare & Medicaid Services (CMS) for upcoming price cuts under the Inflation Reduction Act (IRA), AbbVie is the late | The ...
The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus ...
Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price negotiations that could lower prices for Medicare patients.
The U.S. government plans to lower Medicare costs for Botox by targeting its medical uses, marking a major shift in drug pricing policy.
The Centers for Disease Control and Prevention and the U.S. Food and Drug Administration are investigating several cases across the U.S. of people suffering harmful reactions after receiving Botox ...